Echo Street Capital Management LLC Jazz Pharmaceuticals PLC Transaction History

Echo Street Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $251,564 - $299,629	2,062 Added 47.62%	6,392 $827,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $530,425 - $637,202	4,330 New	4,330 $536,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.16 Million - $1.47 Million	9,142 New	9,142 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $187,748 - $223,643	-1,326 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $287,152 - $355,950	-2,215 Reduced 62.55%	1,326 $206,000
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $424,459 - $515,817	3,541 New	3,541 $451,000
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $229,726 - $267,326	-1,434 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $215,372 - $248,799	1,434 New	1,434 $236,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.